Classifying Misoprostol and Mifepristone as Controlled Substances: Implications for the Management of Non-Abortion Related Conditions

This data note analyzes employer-sponsored insurance and Medicaid claims data to see how mifepristone and misoprostol—two drugs used in the medication abortion regimen—are prescribed for reasons other than abortion including management of miscarriages, abnormal bleeding or hemorrhage, as well as IUD insertions and other conditions.

Read More

‘It Will Set Us Back Multiple Decades’: Why Public Health Experts Are Panicking About the HHS Overhaul

HHS underwent a sweeping restructuring this week, resulting in about 10,000 layoffs across various agencies. With critical programs for things like disease prevention and outbreak response already crumbling, experts believe the fallout from this decision could set public health efforts back by decades. The post ‘It Will Set Us Back Multiple Decades’: Why Public Health…

Read More

Potential Impacts of Increased Immigration Enforcement on School Attendance and Funding

This brief presents research on the impacts of immigration enforcement on children, including school attendance and performance; provides data on the share and number of school-aged children by state who live in immigrant families based on KFF analysis of the 2023 American Community Survey (ACS); and discusses potential implications of declines in school enrollment and/or…

Read More

Trump’s DEI Undoing Undermines Hard-Won Accommodations for Disabled People

For years, White House press conferences included sign language interpreters for the deaf. No longer. Interpreters have been noticeably absent from Trump administration press briefings, advocacy groups say. Gone, too, are the American Sign Language interpretations that used to appear on the White House’s YouTube channel. A White House webpage on accessibility, whitehouse.gov/accessibility, has also…

Read More